Assessing the Safety, Tolerability and Pharmacokinetics(PK) of DZD9008 and the Effect of Low-fat Meal on PK of DZD9008 in Healthy Adult Participants

NCT04909242 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
78
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Dizal Pharmaceuticals